跳至主要内容
临床试验/CTRI/2023/04/051266
CTRI/2023/04/051266尚未招募2 期

A single arm clinical study to evaluate the efficacy add on effect of Ajmodadi vati in the managment of Prameha with special reference to Diabetis mellitus Type2

Bhagwan Kakasaheb Muley0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with fasting blood sugar >126mg/dl upto 200mg/dl and post prandial blood sugar >200mg/dl upto 450mg/dl

排除标准

  • Diabetes mellitus type 2 Acromegaly cushings syndrome and pancreatic disorders
  • Pregnant and lactating mothers
  • Patients with known case of Diabetic nephropathy and retinopathy
  • Patients with gastrointestinal disease liver disease and tumors cardiovascular disease acute myocardial infarction DKA hyperosmolar non ketotic diabetic coma

研究者

发起方
Bhagwan Kakasaheb Muley

相似试验

Study held to see the effect of Ajmodadi Vati on... | 临床试验